Board committees

Novozymes and Chr. Hansen have joined forces to create Novonesis, a leading biosolutions partner. Working closely with our customers, we’re transforming the way the world produces, consumes and lives.

Get to know our proposed Board of Directors, Executive Leadership Team and ownership structure:

novonesis.com

The Board of Directors has established four board committees in order to prepare decisions and recommendations for review and approval by the Board of Directors.


Audit Committee Open Close

The Audit Committee assists the Board of Directors in meeting its responsibilities in the financial reporting process, the system of internal controls, the audit process and the Company’s process for monitoring compliance with laws, regulations, internal policies and positions, including considering the independence of the independent auditor and reviewing the annual and quarterly financial reports.

All members are independent as defined by the Danish Recommendations on Corporate Governance. Two members have expertise and experience in accounting and auditing and the members as a whole have competencies relevant to the industries in which Chr. Hansen operates, as required by the Danish Act on Approved Auditors and Audit Firms. In 2021/2022, the Audit Committee held seven meetings and all members attended all meetings held during the term of their committee membership. For more detailed information on meeting attendance reference is made to p. 67 of the Annual report 2021/22

 

Chair

  • Lise Kaae (financial expert)

Members

  • Dominique Reiniche

  • Jesper Brandgaard (financial expert)


Read the committee's charter and report on the committee’s work.

Nomination Committee Open Close

The Nomination Committee assists the Board of Directors in meeting its responsibilities with respect to the nomination and appointment of members of the Board of Directors and the Executive Board, ensuring that the Board of Directors and the Executive Board are at all times of the appropriate size and composed of individuals with the necessary professional qualifications and experience, and to conduct regular evaluations of the performance of the Board of Directors and the Executive Board.

All members are independent as defined by the Danish Recommendations on Corporate Governance. In 2021/2022, the committee held four meetings and all members attended all meetings held during the term of their committee membership. For more detailed information on meeting attendance reference is made to p. 67 of the Annual report 2021/22.

 

Chair

  • Dominique Reiniche

 

Members

  • Jesper Brandgaard

  • Heidi Kleinbach-Sauter

  • Kevin Lane

     

Read the committee's charter and report on the committee’s work.

Remuneration Committee Open Close

The Remuneration Committee assists the Board of Directors in meeting its responsibilities in regard to establishing, implementing and executing its remuneration policy for the members of the Board of Directors, its committees and the Executive Board. Furthermore, the Remuneration Committee assists the Board of Directors in preparing a general remuneration policy for the Company.

All members are independent, including the chair, as defined by the Danish Recommendations on Corporate Governance. In 2021/22, the committee held four meetings and all members attended all meetings held during the term of their committee membership. For more detailed information on meeting attendance reference is made to p. 67 of the Annual report 2021/22.

 

Chair

  • Dominique Reiniche

Members

  • Luis Cantarell
  • Lise Kaae


Read the committee's charter and report on the committee’s work.

Science & Innovation Committee Open Close

The Science & Innovation Committee assists the Board of Directors in meeting its responsibilities with respect to the Research and Development (“R&D”) strategy of the Company, including the commercialization strategies to bring innovations from R&D to the relevant markets. The purpose is to provide reassurance to the Board that the R&D, technical, regulatory and food safety resources and plans of the Company are appropriately aligned with the agreed business and customer strategies. 

All members are independent as defined by the Danish Recommendations on Corporate Governance. In 2021/22, the committee held five meetings and all members attended all meetings held during the term of their committee membership. For more detailed information on meeting attendance reference is made to p. 67 of the Annual report 2021/22.

 
 

Chair

  • Luis Cantarell

Members

  • Heidi Kleinbach-Sauter

  • Kevin Lane 

     

Read the committee's charter and report on the committee’s work.

Share this with: